General Information |
| Board Constituency: |
None |
| Is your organization legally registered in your country: |
Yes |
| If yes, please enter your registration number: |
93-1669454 |
| Organization Type - Primary: |
Private Sector |
| Organization Type - Secondary: |
Company |
| Organization Description: |
1) RespAI is an AI-powered robust and rapid respiratory disease diagnosis software with the aim to democratize high-quality healthcare in countries with a lack of trained radiologists. Our main focus is to provide high-quality diagnostics to help battle TB and other respiratory diseases.
2) We are interested in tuberculosis because TB has and continues to affect millions of patients worldwide and as healthcare researchers we aim to alleviate patient's health outcomes by democratizing high-quality healthcare for all.
3) Our current product is capable of diagnosing respiratory conditions in 15 disease classes with over 90% accuracy using an ensemble of machine learning algorithms trained over 100,000+ images. Our diagnostic system also includes diagnosis of TB from chest x-ray images and will help with the improvement of TB diagnosis overall in the regular healthcare routine. |
| |
| Do you know about the UNHLM declaration: |
Yes |
Other Organization Information |
| Total number of staff in your organization: |
1 - 5 |
| Number of full-time staff who are directly involved with TB: |
1 - 5 |
| Number of part-time staff who are directly involved with TB: |
1 - 5 |
| Number of volunteers who are directly involved with TB: |
1 - 5 |
| |
| How did you hear about the Stop TB Partnership: |
Internet search |
| If you were informed or referred by another partner of the Stop TB Partnership please tell us who: |
|
| Why do you wish join the Stop TB Partnership: |
Resource mobilization |
| |
| Are you a member of a Stop TB national partnership: |
United States of America |
| Are you in contact with your national TB programme: |
Yes |
| Please tell us how your organization is contributing to your country's national TB control plan: |
| RespAI provides an automated respiratory disease diagnosis system and we are currently working on implementing clinical validation studies with large hospital systems in the US of our computer-aided diagnostic software which will drastically help improve TB patient outcomes by increasing accuracy and speed of diagnosis using AI in patients affected by TB and other respiratory conditions in the US. |
| |
Geographical Reach |
| Which country is your headquarters located in: |
United States of America |
Which countries do you do operate in:
(This includes countries you are conducting activities in) |
United States of America
|
